Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance.
Bahri P, Bowring G, Edwards BD, Anton C, Aronson JK, Caro-Rojas A, Hugman BPJ, Mol PG, Trifirò G, Ilic K, Daghfous R, Fermont I, Furlan G, Gaissmaier W, Geer MI, Hartigan-Go KY, Houÿez F, Neth H, Norgela G, Oppamayun Y, Raynor DKT, Bouhlel M, Santoro F, Sultana J. Bahri P, et al. Drug Saf. 2023 Jun;46(6):517-532. doi: 10.1007/s40264-023-01285-5. Epub 2023 May 23. Drug Saf. 2023. PMID: 37219785 Free PMC article. Review. No abstract available.
Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum.
Beckmann J, Hagemann U, Bahri P, Bate A, Boyd IW, Dal Pan GJ, Edwards BD, Edwards IR, Hartigan-Go K, Lindquist M, McEwen J, Moride Y, Olsson S, Pal SN, Soulaymani-Bencheikh R, Tuccori M, Vaca CP, Wong IC. Beckmann J, et al. Among authors: bahri p. Drug Saf. 2014 Oct;37(10):743-59. doi: 10.1007/s40264-014-0216-1. Drug Saf. 2014. PMID: 25171836 No abstract available.
Benefit-Risk Assessment, Communication, and Evaluation (BRACE) throughout the life cycle of therapeutic products: overall perspective and role of the pharmacoepidemiologist.
Radawski C, Morrato E, Hornbuckle K, Bahri P, Smith M, Juhaeri J, Mol P, Levitan B, Huang HY, Coplan P, Li H; BRACE Special Interest Group. Radawski C, et al. Among authors: bahri p. Pharmacoepidemiol Drug Saf. 2015 Dec;24(12):1233-40. doi: 10.1002/pds.3859. Epub 2015 Oct 12. Pharmacoepidemiol Drug Saf. 2015. PMID: 26456379 Review.
An Update on ISoP Special Interest Groups (SIGs).
McCarthy D, Bahri P, Barnes J, Delumeau JC, Edwards B, Harrison-Woolrych M. McCarthy D, et al. Among authors: bahri p. Drug Saf. 2018 Jan;41(1):1-6. doi: 10.1007/s40264-017-0603-5. Drug Saf. 2018. PMID: 28980202 No abstract available.
48 results